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Abstract
Generating and maintaining gradients of cell density and extracellular matrix (ECM) compo-
nents is a prerequisite for the development of functionality of healthy tissue. Therefore, gain-
ing insights into the drivers of spatial organization of cells and the role of ECM during tissue
morphogenesis is vital. In a 3D model system of tissue morphogenesis, a fibronectin-FRET
sensor recently revealed the existence of two separate fibronectin populations with different
conformations in microtissues, i.e. ‘compact and adsorbed to collagen’ versus ‘extended
and fibrillar’ fibronectin that does not colocalize with the collagen scaffold. Here we asked
how the presence of fibronectin might drive this cell-induced tissue morphogenesis, more
specifically the formation of gradients in cell density and ECM composition. Microtissues
were engineered in a high-throughput model system containing rectangular microarrays of
12 posts, which constrained fibroblast-populated collagen gels, remodeled by the contrac-
tile cells into trampoline-shaped microtissues. Fibronectin’s contribution during the tissue
maturation process was assessed using fibronectin-knockout mouse embryonic fibroblasts
(Fn-/- MEFs) and floxed equivalents (Fnf/f MEFs), in fibronectin-depleted growth medium
with and without exogenously added plasma fibronectin (full-length, or various fragments).
In the absence of full-length fibronectin, Fn-/- MEFs remained homogenously distributed
throughout the cell-contracted collagen gels. In contrast, in the presence of full-length fibro-
nectin, both cell types produced shell-like tissues with a predominantly cell-free compacted
collagen core and a peripheral surface layer rich in cells. Single cell assays then revealed
that Fn-/- MEFs applied lower total strain energy on nanopillar arrays coated with either fibro-
nectin or vitronectin when compared to Fnf/f MEFs, but that the presence of exogenously
added plasma fibronectin rescued their contractility. While collagen decoration of single
fibronectin fibers enhanced the non-persistent migration of both Fnf/f and Fn-/- MEFs, the
migration speed was increased for Fn-/- MEFs on plasma fibronectin fibers compared to
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Fnf/f MEFs. In contrast, the average speed was the same for all cells on collagen-coated Fn
fibers. A Fn-FRET sensor revealed that fibronectin on average was more extended on the
microtissue surface compared to fibronectin in the core. Gradients of collagen-to-fibronectin
ratios and of the fraction of collagen-adsorbed to stretched fibrillar fibronectin conformations
might thereby provide critical cell migration cues. This study highlights a dominant role for
fibronectin in tissue morphogenesis and the development of tissue heterogeneities.
Introduction
Healthy connective tissue maintains a function-specific hierarchical organization of cells and
ECM. Formation of tissue anisotropy is thereby driven by biochemical gradients and physical
factors, including the need to bear the imposed loads while ascertaining in vivo tissue function-
ality and durability [1,2,3,4]. However in pathological conditions, external overloading or
inflammation of fibrous tissue can cause a progressive increase in cell and matrix reorganiza-
tion, as in atherosclerosis [5], ventricular overloading [6], cardiomyopathy [7] and tendon
overload [8]. In addition, replicating and maintaining this native-like architecture of ECM and
cells when engineering tissues in vitro, still remains a challenge. In tissue engineering, where
homogeneous polymeric scaffolds are typically presented to cells, the density of cells and asso-
ciated ECM are found to progressively increase at tissue surfaces [9,10,11,12,13], and in thin
tissues this cannot solely be attributed to diffusion limitations of the supplied nutrients. For
example, oxygen limitations only start at a tissue depth of 200μm [14]. Recently, the increase in
fibroblast density towards tissue surfaces in reconstituted collagenous microtissues, approxi-
mately 40μm thick, was correlated with an increasingly anisotropic distribution of fibronectin
(Fn) [10,13,15]. The emerging shell-like tissues contained a collagen-rich tissue core that was
sparsely populated by cells, but progressively covered by fibronectin-rich surface layers con-
taining high cell densities [10]. However, insight is still missing regarding the underlying mech-
anisms that drive tissue morphogenesis to generate such cell density gradients. In particular, it
is unknown what the role of ECM is and how it affects spatial gradients of the associated pro-
cesses, such as cell migration and force generation. In the current study we asked how fibronec-
tin in the context of collagen gels impacts cell-induced tissue morphogenesis, specifically the
depth-dependent distribution of cells and their ECM.
Fibronectin is a dimeric glycoprotein that consists of two almost identical monomers
[16,17,18]. Cellular fibronectin, as produced by fibroblasts and many other cells, contains addi-
tional segments compared to plasma fibronectin, notably, the EDA and EDB domains
[16,17,18,19,20]. Plasma fibronectin is produced solely by hepatocytes [16] and circulates in
the blood plasma, as well as in other body fluids. Both plasma and cellular fibronectin interact
with cells mostly via the classic integrins αvβ3 and α5β1, but plasma and cellular fibronectin
show distinct downstream effects on cell signaling [19,20,21,22,23,24,25,26], and were thus
shown to have distinct and independent functions during tissue repair [22]. For cellular fibro-
nectin, the EDA domain contains binding sites for α4β1 and α9β1, while no binding sites were
identified so far on the EDB domain [16]. While cells probe their environment, they pull,
stretch and deflect the ECM fibers to which they are attached until homeostasis is reached, or
until they start to migrate. Fibroblasts are unable to migrate into plasma clots when the clots
are depleted of fibronectin [27]. A similar phenomenon is observed for sprouting microvessels
from rat aorta explants that are embedded in rat tail collagen gels [28]. The length of these
sprouting microvessels was observed to increase with increasing concentrations of plasma
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fibronectin added to the collagen gel [28]. The addition of fibronectin was also observed to pro-
mote migration and matrigel invasion by ovarian cancer cells, in a focal adhesion kinase
(FAK)-dependent manner [29]. Since mechanical forces acting on ECM fibers result in confor-
mational changes of fibronectin through stretching and partial unfolding of its domains which
all carry specific binding sites [30,31,32,33], fibronectin can be regarded as a mechanotransdu-
cer [34]. Stretch-induced conformational changes of the protein exposes cryptic binding sites
for fibronectin self-association [32,33,35], reduces the affinity to bacterial adhesins [36,37] and
promotes the osteogenic differentiation of human mesenchymal stem cells [38]. Furthermore,
the otherwise hidden synergy site, which enhances α5β1-integrin binding to fibronectin, gets
exposed when cells pull on fibronectin anchored to rigid but not to soft polyacrylamide sub-
strates, and the exposure of the synergy site correlates with fibronectin-mediated FAK activa-
tion in fibrocarcinoma cells [39].
Major synergies exist between fibronectin and other ECM components during tissue
remodeling and morphogenesis [20]. While it was initially reported that cellular but not plasma
fibronectin is required to induce collagen gel contraction [40], it was later shown that fibronec-
tin-knockout mouse embryonic fibroblasts (Fn-/- MEFs) are still able but limited in their ability
to contract type I collagen gels prepared in fibronectin-depleted growth medium (only a ~30%
reduction in gel volume was observed) [41], whereby gel contractions up to ~80% is observed
with the addition of exogenous plasma fibronectin [41]. Also inhibiting the interaction between
collagen and fibronectin through the addition of a fibronectin-to-collagen binding inhibitor
(R1R2), reduces gel contraction by Fn-/- MEFs in a dose-dependent manner [42] and severely
affects tissue morphogenesis of 3D collagen-fibronectin tissue [43]. Additionally, contraction
of a gel mixture of Fn-/- MEFs, type I collagen and fibronectin was significantly reduced upon
treatment of the gel with anti-β1 or -α5 integrin antibodies [41]. Fibronectin can thus promote
cell-induced collagen gel contraction via the most dominant cell-fibronectin binding integrin,
α5β1 [44]. Not surprisingly, fibronectin provides a template for type I and III collagen assem-
bly in tissue repair and development [45,46].
There is a specific role for fibronectin in regulating tissue morphogenesis, as already well
established in early development, wound healing and in cancer progression. Model systems
using cell-contracted collagen gels gave further insights how fibronectin impacts cell-induced
tissue morphogenesis and the resulting heterogeneous distribution of cells and ECM compo-
nents. By using FRET-labeled fibronectin to sense the conformation of fibronectin in con-
tracted collagen microtissues, Legant et al. [10] showed that two different populations of
fibronectin exist, i.e. collagen-absorbed, more compact fibronectin, as well as cell-assembled
fibrillar fibronectin that was stretched by cell-generated forces [10]. Interestingly, cells were
increasingly located at tissue surfaces with progression of culture time, correlating with the
highest densities of fibrillar fibronectin, but the reason why the cells accumulated on the sur-
face of the contracted gels remained unclear.
Here, the contribution of fibronectin to the collagen gel microtissue morphogenesis was
studied using fibronectin-knockout mouse embryonic fibroblasts (Fn-/- MEFs) and floxed
equivalents (Fnf/f MEFs) [47] in combination with a FRET-fibronectin sensor that can directly
bind to collagen, as unlabeled fibronectin does as well, and gets incorporate by fibroblasts into
their ECM fibrils [30,31]. Since we found here that the presence of plasma fibronectin in the
medium, but not of its fragments, has a major effect on tissue morphogenesis by Fn-/- MEFs,
cellular traction forces were measured using nanopillar arrays in a secondary series of experi-
ments, while migration properties were determined by tracking migrating single cells on single
manually pulled fibronectin fibers.
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Results
Fibronectin is required for the accumulation of cells at the microtissue
periphery
To address the question of how fibronectin impacts cell-induced microtissue morphogenesis,
Fn-/- MEFs and Fnf/f MEFs were mixed with collagen type I and seeded in microwells contain-
ing tissue-constraining posts (Fig 1A–1C). Fibronectin-depleted FBS-rich (10%) growth
medium was added in all experiments with or without supplementation of exogenous plasma
fibronectin. Microtissues produced by Fnf/f MEFs developed into shell-like tissues (Fig 2A and
2B and S1A, S1 and S2 Movies). The core of the collagen scaffold was sparsely populated by
cells whereas the periphery contained a high cell density (Figs 2B and S2B and S2D; S2 Movie).
Contrary to the cells, plasma fibronectin was found to be more evenly distributed throughout
the tissue (Figs 2B and S2B and S2D) as it can directly bind to collagen gel fibers independent
of the presence of cells [10]. This confirms previous findings that 3T3 fibroblasts initially
immersed in isotropic collagen gels drive the formation of a shell-like tissue morphology
[10,15]. In contrast, microtissues contracted by Fn-/- MEFs displayed a strikingly different
depth-dependent distribution of the cells 72h after seeding. In the absence of fibronectin, the
overall distribution of Fn-/- MEFs in the collagen scaffold remained more homogenous (Figs
2C and S2B; S3 Movie), i.e. distributions of nuclei and collagen highly overlapped (S2B Fig).
Adding exogenous plasma fibronectin at the start of the Fn-/- MEFs culture, restored the shell-
like composition of their floxed equivalents (Fig 2B), with plasma fibronectin being present
throughout the complete tissue and also covering the collagen core (Figs 2D and S2B and S2E;
Fig 1. Model platform of tissuemorphogenesis to generate fibroblast-contracted collagenmicrotissues. (A) An 8x8 microwell PDMS template was
adhered to a petri dish containing a glass bottom. The white square indicates one single well in which a microtissue was engineered, as depicted in (B):
Top view of a biaxially constrained microtissue in a single well of 1125×1125μm, composed of rat tail collagen type I mixed with MEFs. After contraction,
tissues measure approximately 800×800×50μm. The white square indicates the area scanned with confocal microscopy (246×246μm) (C) Side view of 4
posts from one microwell. Post diameter was 75μm at the base and 125μm at the top, with a total height of 125μm.
doi:10.1371/journal.pone.0160369.g001
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S4 Movie). Interestingly, a much thicker fibrillar layer of plasma fibronectin was assembled by
Fn-/- MEFs at the tissue top surface, different from Fnf/f MEFs equivalents, also visible from
overall tissue thickness (Fig 2B vs 2D). The formation of shell-like tissues in the presence of
plasma fibronectin for both cell types mostly established between 48 and 72h (S1A and S1B
Fig; for floxed cells S5, S6 and S1 Movies (24h, 48h and 72h, respectively) and for knockout
cells S7, S8 and S3 Movies (24h, 48h and 72h, respectively)).
Exposure to fibronectin enhances Fn-/- MEF migration speed
To further understand why Fn-/- MEFs continued to reside within the collagen scaffold in the
absence of fibronectin, we asked whether exposure to fibronectin versus collagen directly
affects cell migration speed and persistence. Therefore, cell migration speed and persistence
was quantified in single cell assays where fibroblast-populated beads were seeded on manually
pulled plasma fibronectin fibers [32] (Fig 3A), since we know that the conformation of fibrillar
Fig 2. Fibronectin contributes to the depth-dependent separation of cells and collagen scaffold in microtissues.Microtissues, cultured for 72h, were
either engineered from Fnf/f MEFs in the absence (A) or presence of plasma fibronectin (B), or from Fn-/- MEFs in the absence (C) or presence of plasma
fibronectin (D). The depth-dependent distributions of cells and ECM components in a single tissue are represented by volume rendering of a cropped section
of the Z-stack using Imaris software in a bottom and top view (1st and 2nd column) and a maximum projection cross-section of a cropped section of the tissue
Z-stack with associated depth-dependent intensity histogram from the full Z-stack (3rd and 4th column, nuclei in blue; collagen in green and plasma fibronectin
in red)). Tissue depth in the histograms is represented as the distance from the location in the tissue with maximum collagen intensity (0μm). The depth-
dependent intensity histogram of all tissues combined is depicted in the 5th column, which represents the raw data. Fnf/f MEFs produce shell like tissues,
where cells reside on both sides of the collagen core (A and B). However, in absence of fibronectin, Fn-/- MEFs predominantly reside in the collagen core (C).
Fn-/- MEFs supplemented with fibronectin not only migrate towards tissue surfaces, but also assemble fibrillar fibronectin, primarily at the top surface (D).
Percentage overlap of collagen and nuclei at the tissue bottom, core and top are quantified in S2 Fig.
doi:10.1371/journal.pone.0160369.g002
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Fig 3. Average cell migration speed and persistence along fibers depends on the type of ECM coating. (A)
Experimental setup for assessing migration speed and persistence of cells on manually pulled plasma fibronectin fibers.
MEFs migrated frommicrocarrier beads onto fibronectin fibers, either left untreated, or decorated with rat tail collagen type I
monomers. (B) Migration speed of single cells was tracked every 15min during 24h and averaged; speed was measured only
for single cells (collectively migrating cells were excluded) using the fiber as their substrate. Non-persistently migration cells,
i.e. cells that changed migration direction at least once, are marked by a magenta-colored circle. Fn-/- MEFs, compared to Fnf/f
MEFs, displayed a significant increase in migration speed on pFn fibers (* p<0.05). Decorating pFn fibers with collagen
however significantly reduced migration speed of Fn-/- MEFs, to attain values that lacked a significant difference with Fnf/f
MEFs on uncoated fibers. Migration speed of Fnf/f MEFs was not affected by the fiber coating. Migration persistence was
Fibronectin Drives Tissue Morphogenesis
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fibronectin, which is often stretched by the cells, is far more extended compared to that of
fibronectin adsorbed to flat glass substrates [48] or directly to collagen gels [10] and that the
fibronectin conformational distribution within these single fibers closely resembled those
observed in a native 3D extracellular environment [32]. The fibers were either left uncoated or
were decorated with rat tail collagen type I (matching that of the 3D scaffolds in this study).
The aim here was thus to construct fibers that are similar in their physical properties (diameter,
rigidity, etc.), but present either fibrillar fibronectin versus collagen 1-decorated fibronectin
fibers. To assess solely how cell migration is affected by the presence of different ECM compo-
nents presented by single fibers, the migration speed and persistence of individual MEFs was
tracked using fibronectin-depleted growth medium. Two major observations can be made:
First, while the Fnf/f MEFs and the Fn-/- MEFs were highly persistent walkers on the single
plasma fibronectin fibers, collagen I decoration increased the turn-around events for both (Fig
3B and 3D). Almost half of both Fnf/f and Fn-/- MEFs changed migration direction over the
course of the observation (Fig 3B and 3C, magenta-colored circles). Second and perhaps sur-
prising, the migration speed of Fn-/- MEFs on plasma fibronectin fibers was significantly higher
compared to Fnf/f MEFs (Fig 3B and 3D), but decorating the plasma fibronectin fibers with col-
lagen significantly reduced the migration speed of the Fn-/- MEFs to levels approaching those
of Fnf/f MEFs (Fig 3B), while collagen coating had little effect on the migration speed of the
Fnf/f MEFs. However, persistently migrating cells on collagen decorated fibers did not show a
significantly different average speed when compared to non-persistent cells (assessed for both
Fnf/f and Fn-/- MEFs individually using Student’s T tests). The efficacy of the collagen coating
covering the Fn-fibers was verified by staining for the different components after having
tracked the cells in real-time (Fig 3C).
Fibronectin enhances the generation of cell traction forces
Since cell-generated forces drive tissue morphogenesis [2,3,49,50,51,52], we next asked how the
presence of plasma fibronectin in the medium might affect the generation of cell traction
forces. Fnf/f or Fn-/- MEFs were seeded on nanopillar substrates coated with fibronectin, or
vitronectin (which binds αv, but not α5 integrins), with or without exogenous plasma fibronec-
tin (full-length or fragments) in the medium (Fig 4A). Total strain energy [53,54] was calcu-
lated from the pillar deflections measured 2h and 24h after cell seeding (Fig 4B; S3 Fig for
average strain energy per pillar). A slight increase was observed for the total strain energy
between 2h and 24h for almost all groups, associated with an increased spreading area (as visi-
ble from the decreasing average strain energy in time per pillar, S3 Fig), in agreement with pre-
vious literature [55]. On fibronectin-coated nanopillars, Fn-/- MEFs generated significantly
lower (~45%) strain energy in the absence of exogenously added fibronectin to the growth
negatively affected by collagen decoration, i.e. both Fn-/- and Fnf/f MEFs changed migration direction significantly more often,
when compared to their counterparts migrating on pFn fibers. A significant difference in migration speed between non-
persistent and persistent cells was not detected. (C) Confirmation of the presence of collagen coating after termination of the
migration assay (at 24h). The stained collagen is unlikely to originate from the migrating Fn-/- MEFs, since a specific rat-
antibody for collagen is used, the medium does not contain ascorbic acid, and performed experiments were short-term (24h).
(D) Raw data of cellular migration speed on manually pulled plasma fibronectin (pFn) fibers, untreated or decorated with
collagen I monomers. For each condition, a number of 22 cells (y-axis) were tracked every 15min in at least 2 independent
experiments. The color of each dot represents the migration speed (corresponding to the speed, indicated in the bar at the
right) of a single cell at a specific time point (x-axis). Although manual tracking of the cells from one time point to the next is
susceptible to the introduction of human errors by misinterpretation of the cell location, average cell speed as represented in
panel B, is hardly affected. Cells were tracked for 24h maximum, however when encountering other cells, or when leaving the
fibronectin fiber, cell tracking was terminated. Since Fn-/- MEFs had a high migration speed, they more quickly encountered
other cells, and were therefore often tracked for a shorter time. Non-persistent cells are indicated by a magenta-colored circle
just next to the y-axis.
doi:10.1371/journal.pone.0160369.g003
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Fig 4. Total strain energy of fibroblasts on SU-8 nanopillar arrays. (A) Experimental setup for measuring cell-induced
nanopillar displacement: Pre-labeled MEFs (red) were seeded on plasma fibronectin (pFn) or vitronectin-coated nanopillars
for 30min in Fn-depleted FBS-rich (10%) media (SEM image added at the right, showing how fibroblasts deflect the posts).
Pillars have a diameter of 250nm, a height of 1.5μm and center to center distance was 800nm. Medium was supplemented
without or with 45nM fibronectin (full-length, or the 40k, 70k or 120kDa fragments), during cell seeding, and pillar
displacements were measured 2 and 24 hours after cell seeding. (B) Total strain energy per cell, 2h and 24h after seeding, for
different pillar coatings (fibronectin versus vitronectin) and in the presence of exogenous pFn and of its fragments. For pillars
Fibronectin Drives Tissue Morphogenesis
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medium for both time points when compared to Fnf/f MEFs. The addition of exogenous plasma
fibronectin to the medium fully rescued total strain energy by Fn-/- MEFs to match their floxed
equivalents. This is surprising since in both cases, cells are exposed to plasma fibronectin pres-
ent as coating on the nanopillars.
To detect the extent to which fibronectin-coating alone affected the total strain energy, the
experiment was repeated for Fn-/- MEFs on vitronectin coated nanopillars, again for both 2h
and 24h after seeding. Vitronectin coating significantly reduced total strain energy (~35%),
compared to fibronectin coating (Fig 4B; S3 Fig for average strain energy per pillar). On vitro-
nectin-coated pillars, the addition of exogenous plasma fibronectin to the medium again fully
rescued the strain energy generated by Fn-/- MEFs (Fig 4B; S3 Fig for average strain energy per
pillar). Hence, fibronectin, both as substrate coating and to a far greater extend when present
in the growth medium, increased the total cellular strain energy. Since fibronectin contains
binding sites for various integrins [16], we next asked whether exogenously added full-length
plasma fibronectin was required to upregulate cell traction forces, or whether certain fibronec-
tin fragments, none of which can undergo fibrillogenesis, are equally efficient. Fn-/- MEFs were
therefore seeded on vitronectin coated nanopillars and exposed to fibronectin fragments sup-
plemented to the medium. The 70kDa N-terminal fibronectin fragment (repeats FnI1-9 and
FnII1-2) [56] provides integrin binding sites for α5β1 and contains the collagen/gelatin binding
region [16]. The 40kDa C-terminal fibronectin fragment (repeats FnIII12-14) [56] contains the
heparin binding domain II, while the 120kDa central fragment (repeats FnIII1-11) [56] provides
many integrin binding sites, among others the RGD epitope, the α5β1 epitope and the synergy
site [16,41]. Although addition of the 70kDa fibronectin fragment significantly increased the
total cellular strain energy (~50%) at both time points, it did not reach the strain energy levels
generated in the presence of full-length fibronectin (Fig 4B). This 70kDa-mediated increase is
likely to be caused by a modest contamination of what could be full length fibronectin, as
detected by Western blotting of the 70k fragment using a polyclonal fibronectin antibody (S4
Fig). Also the other fibronectin fragments used (40kDa and 120kDa) did not increase total
strain energy, irrespective of the time point. Thus, the presence of full-length fibronectin in the
medium, and not of its fragments, is required to fully rescue the cell traction forces of Fn-/-
MEFs.
Full-length fibronectin is required for the development of steep cell
density gradients
Since the magnitude of traction forces and developing tissue heterogeneity may be linked, Fn-/-
MEFs were mixed with collagen I to produce microtissues, while being exposed to the different
fibronectin fragments (40, 70 or 120kDa) that were supplemented to the growth medium from
the start of culture. Even though all of these fragments were found to bind to the collagen gel,
cell nuclei remained homogeneously distributed throughout the collagen gel (Figs 5 and S2C;
S9–S11 Movies). Tissue contraction appeared to be further limited by the addition of the frag-
ments, since the tissues were generally observed to be thicker than Fn-/- MEFs in collagen only
coated either with fibronectin or vitronectin, pFn in the medium upregulates total strain energy generated by Fn-/- MEFs
approaching those of Fnf/f MEFs. On pFn-coated nanopillars, addition of pFn in the medium significantly increased total strain
energy per Fn-/- MEF attaining values that equal Fnf/f MEFs. Vitronectin coating significantly decreased the strain energy by
Fn-/- MEFs (indicated by #). On vitronectin coated pillars, the 70kDa fragment significantly increased strain energy of Fn-/-
MEFs (indicated by £), which is likely to be caused by a possible contamination of full length fibronectin in this particular
fragment, S4 Fig. However, only full length exogenously added pFn rescues total strain energy by Fn-/- MEFs on fibronectin or
vitronectin-coated pillars to meet their floxed (Fnf/f MEFs) counterparts. For a representation of the average strain energy per
pillar, see S3 Fig.
doi:10.1371/journal.pone.0160369.g004
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(Fig 2C). Thus, cells require full-length fibronectin for tissue morphogenesis, i.e. the accumula-
tion of fibroblasts at the surface of the contracted collagen gels.
Gradient of fibronectin conformations, from the core to the microtissue
periphery
Since a previous study showed that FRET-labeled plasma fibronectin is assembled by 3T3 cells
into fibrillar ECM at the microtissue periphery, much more than in the core where it was
mostly observed to adsorb to collagen fibers [10], FRET-labeled plasma fibronectin was added
to the growth medium of Fn-/- versus Fnf/f MEFs-populated microtissues to assess its depth-
dependent conformational gradients. The FRET signal (calibrated using previously designed
methods [31], S5 Fig) was detected after 24, 48, 72 and for Fn-/- MEFs also 96h after the start of
culturing. Fibronectin was observed to be highly stretched at the tissue surfaces (corresponding
to low FRET) that gradually decreased (corresponding to high FRET) towards the core (Figs
6A, S12–S18 hin for Fn-/- MEFs, tissues grew thicker over time (distributions widened in time,
similar to the results shown in S1B Fig). For both Fn-/- and Fnf/f MEFs, the complete FRET his-
tograms of fibronectin moved over time to lower FRET values, while roughly maintaining their
shape (Fig 6A, graphs at the right). This decrease in average Fn-FRET with culture time hap-
pens as the cells contract the collagen gels, coinciding with a possible change in the ratio of col-
lagen-absorbed, more compact fibronectin vs extended fibrillar fibronectin assembled from the
Fig 5. Fibronectin fragments (40, 70, 120kDa) do not contribute to the depth-dependent separation of cells from the collagen core.Microtissues,
cultured for 72h, were engineered from Fn-/- MEFs mixed with rat tail collagen type I in the presence of fibronectin fragments, either 40kDa (A), 70kDa (B) or
120kDa (C). In the presence of the fibronectin fragments, Fn-/- MEFs predominantly resided in the collagen core. The depth-dependent distributions of cells
and ECM components in a single tissue are represented by volume rendering using Imaris software in a bottom and top view (1st and 2nd column) and a
maximum projection cross-section of the tissue with the associated depth-dependent intensity histogram (3rd and 4th column, nuclei in blue; collagen in green
and fibronectin fragments in red, all stained using a polyclonal antibody). Tissue depth in the histograms is represented as the distance from the location in
the tissue with maximum collagen intensity (0μm). The depth-dependent intensity histogram of all tissues combined is depicted in the 5th column, which
represents the raw data. Percentage overlap of collagen and nuclei at the tissue bottom, core and top are quantified in S2 Fig.
doi:10.1371/journal.pone.0160369.g005
Fibronectin Drives Tissue Morphogenesis
PLOS ONE | DOI:10.1371/journal.pone.0160369 August 26, 2016 10 / 24
growth medium by fibroblasts [10]. Remarkably, from the 48h time point onwards, the FRET-
ratios in the core of the collagen gels contracted by the Fn-/- MEFs lagged behind in time
approximately 24h, compared to Fnf/f MEFs.
Discussion
Since the underpinning mechanisms that drive the formation of cell gradients and gradients of
ECM composition in tissues and engineered tissue scaffolds are not yet resolved [9,10,11,12,20,
21,22,27,28,41,42,43,45,57], we exploited 3D collagen-derived microtissues as model system to
investigate the role of fibronectin in such processes. During contraction of the collagen gels by
fibroblasts, cells accumulate at the microtissue surface (S1 and S2 Figs), in agreement with
Fig 6. The Fn-FRET probe reveals a steep gradient of fibronectin conformations. (A) MEFs embedded in collagen type I gels were incubated up to 96h
in Fn-containing growth medium supplemented with trace amounts of FRET-Fn. The left panel displays representative cropped average intensity projection
images showing the depth-dependent FRET signal in microtissue cross sections at the indicated time points. The right panel shows the distribution of the
FRET ratio throughout all tissue Z-stacks for each measured tissue (images were taken every 1μm in the Z-direction). The maximum FRET ratio was used to
set tissue depth to 0μm. The colored bar in between both graphs represents the color-coded pFn-FRET ratio, corresponding to the left panel. Values
correspond to FRET ratios for fibronectin in solution progressively denatured by GdnHCl, as depicted in S5 Fig. For both the left and right panel, the average
pFn-FRET-ratios decreased from the tissue core towards the outer surfaces. In addition, although the shape of the fibronectin conformational distribution
remains unchanged with increasing culture time, average FRET ratios drop with time, whereby Fn-/- MEFs lag behind on Fnf/f MEFs approximately 24h (see
also panel B). (B) Comparison of maximum pFn-FRET values between groups (representing the average value at 0μm tissue depth), confirming that
maximum values for Fn-/- MEFs at time point 48h and 72h are significantly higher compared to Fnf/f MEFs. The * represents a significant difference (p<0.05)
between time-matching groups, assessed with student t-test.
doi:10.1371/journal.pone.0160369.g006
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previous observations [10,13]. Using fibronectin knockout (Fn-/-) versus floxed mouse fibro-
blasts (Fnf/f), we found that fibronectin plays a crucial role in directing the accumulation of
cells at the tissue surface (Fig 2). The current study revealed that the absence of fibronectin
abolished the accumulation of cells at the tissue surfaces (Fig 2C). The microtissue platforms
allowed us to show that the presence of exogenous plasma fibronectin, but not of the 40kDa,
70kDa or 120kDa fibronectin fragments, rescued the ability of knockout fibroblasts to accumu-
late at the tissue surface (Figs 2 and 5). This is especially interesting in the context of the ability
for full-length fibronectin to undergo fibrillogenesis, which is lacking for the fibronectin frag-
ments alone [41,58,59]. This observation supports the possibility that gradients in the confor-
mation of fibronectin, as probed here by our Fn-FRET sensor, perhaps in combination with
changing fibronectin-to collagen ratios, direct tissue morphogenesis by guiding cells towards
the tissue surfaces.
Cell migration assays on single fibers revealed that Fn-/- MEFs migrate faster on plasma
fibronectin fibers, when compared to collagen-decorated fibronectin fibers (Fig 3). In contrast,
Fnf/f MEFs show similar migration speeds, irrespective of the Fn-fiber coating. The positive
effect of fibronectin on the migration properties of Fn-/- MEFs was previously shown in a
scratch assay, where the addition of plasma or recombinant wild type fibronectin increased
wound closure by Fn-/- MEFs on 2D collagen coated surfaces [42,59]. Also, C2C12 cells migrate
further on fibronectin-coated surfaces, compared to gelatin [60]. In 3D, fibronectin depletion
from plasma clots prevented fibroblast invasion [27], and invasion of collagen constructs by
tumor cells is enhanced upon addition of exogenous fibronectin [61].Here we show that colla-
gen decoration of fibronectin fibers enhanced non-persistent migration by both Fnf/f and Fn-/-
MEFs (Fig 2). This may explain why Fn-/- do not accumulate at tissue surfaces in the absence of
fibronectin. Although Fnf/f MEFs were equally affected by collagen decoration of fibronectin
fibers in decreasing persistent migration, our data show that their ability to produce cellular
fibronectin allows them to accumulate at microtissue surfaces, even in the absence of plasma
fibronectin. A possible explanation lies in the key difference between the manually pulled fibers
and 3D: as the Fnf/f cells migrate on collagen-decorated fibers, they produce and assemble cel-
lular fibronectin matrix underneath themselves which might override the collagen “effect” seen
in the accelerated movement of the Fn-/- cells. In 3D, the cells can encounter endogenous fibro-
nectin produced by other cells while they migrate through the ECM. While we acknowledge
that directly relating observations made from cells migrating on manually pulled fibers to phe-
nomena in 3D cell-assembled ECM is difficult, manually pulled fibers and cell-derived ECM
fibers do share similarities. The conformational distribution of Fn is similar on both types of
fibers [32]. Another constraint that potentially limits Fn-/- MEFs to accumulate at tissue sur-
faces on collagen scaffolds is the required presence of MMPs for migration through collagen
ECM of small pore sizes [62]. Since fibronectin is known to upregulate the production of vari-
ous MMPs [26], this could be a means by which Fn-/- MEFs travel through the collagenous rich
ECM to accumulate at the tissue surface. Additionally, fibronectin was shown to induce cell
proliferation of Fn-/- MEFs in 3D collagen constructs [43,63]. The addition of fibronectin to
Fn-/- MEFs in our setup very likely also resulted in increased proliferation, as visible from the
volume rendered images, compare Fig 2C with 2D. However, since the tissue core is completely
deprived of cells with the addition of fibronectin after 72h, it seems unlikely that local prolifera-
tion at tissue surfaces has been the sole factor to drive the special separation of cells and ECM,
i.e. cell migration through the ECM is proposed to have played a dominant role. Taken
together with our finding that Fn-/- MEFs embedded in a 3D collagen scaffold resided in the
collagen core (Fig 2), and the above-mentioned literature, we conclude that the presence of
fibronectin is essential and drives the formation of a microtissue with well-defined gradients in
cell density and ECM composition.
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We furthermore observed that plasma fibronectin added to the medium upregulated the
generation of traction forces by Fn-/- MEFs pulling on nanopillars coated with plasma fibronec-
tin compared to vitronectin as probed 2h and 24h after cell seeding (Fig 4). In agreement with
these results, previous work showed that type I collagen gel contraction by Fn-/- MEFs is lim-
ited when fibronectin fragments or vitronectin was added to the gel, when compared to adding
full-length fibronectin [41]. Additionally, fibronectin upregulates 3T3 fibroblast contractility
and migration compared to RGD-only modified substrata [64], and that vitronectin and fibro-
nectin, although they share binding sites for several integrins, namely αvβ1 [65], αIIbβ3 (plate-
let integrin), α8β1 and αvβ3 [44], are distinct in αvβ5 (vitronectin) versus α5β1 and αvβ6
integrins (fibronectin) [44]. Our finding that fibroblasts apply enhanced traction forces, giving
rise to an enhanced total strain energy to fibronectin versus vitronectin coated pillars is in
agreement with the literature, i.e. integrin α5β1 but not αvβ3 was shown to increase the ability
of fibroblasts to sustain force [66], and quantitative proteomics linked αv-class integrins to a
GEF-H1-RhoA pathway coupled to the formin mDia1, but not myosin II, and α5β1 integrins
to a RhoA-Rock-myosin II pathway [67]. Strikingly, only the presence of full-length plasma
fibronectin in the medium, and not of its fragments, could recover the forces by which Fn-/-
MEFs pulled on either vitronectin or fibronectin-coated nanopillars. The 70kDa fragment par-
tially rescued the forces; however this is very likely the result of a minor contamination with
possible full length fibronectin as shown by Western blot (S4 Fig). Consequently, not just the
integrin junctions formed with surface-bound vitronectin, but the presence of fibronectin in
the medium positively contributes to cellular traction force generation, suggesting activation of
additional integrins through adsorption of fibronectin from solution to the cell membrane sur-
face. This mode of integrin activation is supported by previous studies performed on fibroblasts
adhering to RGD-functionalized supported lipid membranes and showing that integrin activa-
tion occurs before the cells apply tensile forces to those integrins [68]. Such effect, i.e. the effect
of a soluble protein in the growth medium on cell behavior was also recently demonstrated for
FAK-activation in freely suspended cells in growth medium by adding soluble collagen [39].
Although a direct extrapolation of results from nanopillars to 3D constructs is difficult to
make, lower force generation in the presence of fibronectin fragments, compared to full-length
fibronectin, corroborates with our observation in the 3D constructs that tissue compaction in
the Z-direction appeared to be limited in the presence of fibronectin fragments, compared to
all other groups. The latter agrees with a study by Hocking et al. [41], who also observed limited
gel contraction in the presence of the same fragments.
The high cell densities at the microtissue surfaces correlated with fibronectin that showed
significantly lower FRET than regions in the core of the microtissue (Fig 6). Since we show that
the fibronectin FRET-profile changes significantly at the length scale of a single cell, a depth-
dependent gradient of fibronectin conformations in these microtissues exists, from more com-
pact in the core of the contracted collagen to more extended and partially stretched fibrillar
fibronectin at the tissue periphery. Since it was shown recently [39] that fibronectin-mediated
FAK activation is dependent on the mechanical tension acting on fibronectin, which may
expose its otherwise hidden synergy site to integrin α5, the accumulation of fibroblasts at the
microtissue surfaces may thus originate from increasing the fraction of collagen-adsorbed to
stretched fibrillar fibronectin conformations, from the tissue core to the surface, which might
thereby provide conformational-dependent guidance cues. Different fibronectin conformations
could also indirectly act as a cell guiding cue by differential exposure of binding sites for che-
moattractant growth factors (e.g. PDGF, VEGF, TGFβ and FGF) [19,69,70,71]. The preferred
accumulation of cells at the top surface of microtissues, compared to the bottom, is a feature
that has been observed before as well [10], but the causative factors for this phenomenon are
still unknown. Microtissues have previously been observed to contract around posts within
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12h [15,72] and are thus suspended up to 75μm above the substrate at a stage well before asym-
metries in cellular distributions from apical to basal appear. Although oxygen limitations were
shown to only be a limiting factor in tissues that exceed 200μm [14], and our microtissues are
approximately 4 times thinner (~50μm), accessibility of larger molecules by cells at the basal
side may be limited especially in the first phase of gel contraction when compared to the apical
side. We thus acknowledge that the difference in cell density from apical to basal may be driven
by chemotaxis and thereby presents an artifact of the model system. The central part of micro-
tissues contains high collagen densities (Fig 2) and high FRET-values (Fig 6), while moving
towards the tissue surface, collagen density and FRET progressively decrease. The fibronectin
FRET-ratios in microtissues populated by Fn-/- MEFs were shifted to significantly higher values
at the time points 24h, 48h and 72h (Fig 6B), respectively, indicating that Fn-/- MEFs may con-
tract the tissues at a slower rate. Locations in the tissue that contain high collagen densities
may correlate with a high degree of fibronectin that is absorbed to the collagen, as shown ear-
lier for collagen-adsorbed fibronectin compared to fibrillar fibronectin [10]. The FRET
decrease over time in the core may indicate that the initially adsorbed fibronectin may be grad-
ually released from the collagen over time, thus changing the ratio between absorbed and fibril-
lar fibronectin.
In conclusion, fibroblasts accumulated at microtissue surfaces in the presence of full-length
fibronectin. Building order from randomly assembled cells requires cell migration and force
generation, and both were shown here to be promoted by full-length fibronectin on manually
assembled fibers and nanopillars, respectively. Unraveling fibronectin-induced mechanisms
that drive spatial organization of cells and ECM, and thus tissue morphogenesis, is of vital
interest in development, as well as to build and maintain engineered tissue functionality and
durability.
Materials and Methods
Microtissue fabrication
A previously developed model system was used [73,74], composed of an array of 8 by 8 micro-
wells, with each well containing 12 posts with a narrow base and wide top (total height 125μm)
in a square setup (Fig 1). Before use, the model systems were made hydrophilic by plasma treat-
ment (1 min at 100W) to facilitate gel seeding. Subsequently, they were sterilized by treatment
with 70% alcohol for 30min and UV exposure for 15min, and finally treatment with 0.2%
Pluronic F127 (BASF) for 2 min to reduce cell adhesion.
Fibronectin-knockout (Fn-/-) or fibronectin floxed (Fnf/f) mouse embryonic fibroblasts
(MEFs) [25,47,75] were obtained from Professor Rainhard Faessler (Max-Planck Institute for
Biochemistry, Martinsried, Germany). Cells were added to a gel mixture of growth medium
(DMEM low glucose with glutamax, Gibco; 10% Fn-depleted FBS, Biowest; 1% penicillin/strep-
tomycin, Gibco), collagen type I (final concentration 1mg/mL, rat tail, BD Bioscience) and
sodium hydroxide to neutralize the pH of the acidic collagen. Gels were mixed with cells to
attain a final density of 106 MEFs per mL gel. All MEFs used were below passage 10. To each
microwell, approximately 0.16μL of the cell-gel mixture was pipetted (the volume of a single
well). During this procedure, microwells were kept on ice to prevent evaporation of the gel.
Gels subsequently polymerized in an incubator at 37°C, 5% CO2 for 10min. To prevent dehy-
dration of the gel during polymerization, the petri dish was inverted and sterile water was
added to the lid. After polymerization, growth medium was added to the gels, which contracted
around the posts in approximately 6h [73,74]. Where indicated, the growth medium was sup-
plemented with 40nM fibronectin (unlabeled plasma fibronectin, single or double (FRET)
labeled plasma fibronectin, or fibronectin fragments, i.e. 40kDa, 70kDa or 120kDa).
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Supplemented concentrations of full-length fibronectin, as indicated in this manuscript, are
derived from the molecular weight of the monomer and thus theoretically contain twice the
amount of binding sites compared to added fragments. Fibronectin fragments are purchased
from Sigma and obtained through proteolysis of human plasma fibronectin. FRET-labeled
fibronectin was always mixed with unlabeled fibronectin at a ratio of 1:10 to avoid signal from
intermolecular FRET. Fibronectin was added just after tissue seeding and remained in the cul-
ture throughout the complete experiment. Engineered microtissues were cultured up to 96h.
Visualization and distribution analysis
After the designated culture period, microtissues were fixed in 10% formalin for 30min and
permeabilized for 30min in 0.5% Triton-X in PBS (visualization of FRET-fibronectin was per-
formed in absence of triton-X treatment). The following antibodies were used for specific stain-
ing of ECM components and cell nuclei: 1F10C2 (Chondrex) for rat tail collagen type I,
ab23750 (Abcam) for fibronectin, and Dapi (Fluka) for cell nuclei. Exogenously added plasma
fibronectin was pre-labeled with Alexa488 (A20000, Invitrogen). Z-stack fluorescent images
were taken with a confocal microscope (Leica SPX5). The pinhole of the photo-multiplier was
set to the optimal width for the used 63x, 1.2N.A. water immersion lens (Zeiss Plan Apo CS).
Photo-multipliers accepted wavelength regions of 418–461nm for Dapi, 498-544nm for fibro-
nectin (alexa488), or 643-739nm for collagen (alexa633). Microtissues anchored to the posts
were visualized through the glass bottom of the petri dish. Individual images were taken every
1μm through the complete tissue depth, which measured 246 x 246μm each (as shown in Fig
1B). No additional image processing was performed. A representation of the distribution of
cells, collagen and fibronectin throughout the tissue depth was obtained by processing maxi-
mum projection images from the Z-stacks using ImageJ, which were cropped in the x-direction
to 75μm for a clear representation of the cell and protein distributions in the Z-direction. Emis-
sion intensity profiles throughout the tissue depth were obtained using ImageJ for each tissue,
using the complete stack, not the cropped version. For each condition, intensity profiles were
normalized, i.e. maximum emission for each channel was set to 1, after which profiles within
the same condition were averaged. Averaging was performed after shifting the intensity profiles
over the x-axis to have the maximum collagen intensity slice at the exact same location (set at a
tissue depth of Z equals 0μm), explaining the lack of a standard deviation at this specific depth
for collagen. Tissue depth is represented as distance from the location in the tissue with maxi-
mum collagen intensity, which therefore equals the arbitrary value of 0μm.
Imaris software was used to produce volume rendered representative parts (cropped to
100x100μm) of the 3D stacks from single tissues. Contrast and brightness of individual chan-
nels (nuclei, collagen and fibronectin) were visually optimized for each tissue. Direct compari-
son between samples in terms of intensity is not valid. The volume rendered images merely
aim to give the reader a 3D view of the differences between cellular distributions throughout
tissue depth.
The distribution of cells and ECM (collagen and fibronectin) throughout microtissue thick-
ness was quantified as follows. For each tissue, the tissue core was defined by all Z-stack slices
from the collagen channel that had a normalized fluorescent intensity of 0.5 or higher (S2A
Fig, vertical dashed line intersecting with the green line: representing collagen), thereby defin-
ing 3 regions in the tissue, i.e. bottom, core and top. Intensity values belonging to the three dif-
ferent regions, were summed and normalized to the total sum of intensity values, thus
normalizing to 100%. Since high intensity values for the collagen channel are taken as a refer-
ence, the tissue core contains the majority of the collagen. Tissue bottom and top of the micro-
tissues thus have limited amount of collagen and represent the basal and apical side,
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respectively. Subsequently, the sum of intensity values for the Dapi and fibronectin channels
were calculated in the same way, but always based on the ‘bottom, core, top’-distribution of the
collagen channel. The visual representation of these distributions thus represent the fraction of
cells or fibronectin that overlap with the collagen core, and the top and bottom surface of the
microtissues. To determine significant differences between bottom, core and top, One-Way-
ANOVA, Bonferroni post hoc test was applied to the Dapi and fibronectin distributions.
Fibronectin isolation, fluorescent labeling, and FRET imaging and
analysis
Fibronectin was isolated, (FRET-)labeled and analyzed, including a characterization via chemi-
cal denaturation curves, as previously described [31]. In short, fibronectin was purified from
human plasma (Swiss Red Cross). The cysteines on the fibronectin modules FnIII7 and FnIII15
were labeled with Alexa Fluor 546 as acceptor fluorophores (A, maleimide, Molecular Probes),
whereas amines were randomly labeled with Alexa Fluor 488 as donor fluorophores (D, succi-
nimidyl ester, Molecular Probes). The labeling ratio of Fn-DA was determined by measuring
the absorbance of at 280, 498 and 556nm. On average, 13.5 donors and 4.0 acceptors were
labeled on each fibronectin dimer. Upon stretching fibronectin, the distance between the multi-
ple acceptors and donors increases resulting in a reduction in the acceptor to donor intensity
ratios, here referred to as FRET (IA/ID). The use of multiple donors and acceptors prevents the
calculation of FRET efficiency, but is sensitive to a large range of conformations. FRET–labeled
fibronectin in PBS was stored at -20°C and added to cultures immediately after thawing.
All images that involve FRET measurements were acquired with an Olympus FV-1000 con-
focal microscope with a 40×0.9 N.A. water immersion objective, with a set pinhole diameter of
200μm. Slices from each Z-stack were acquired at 318x318μmwith a slice spacing of 1μm. All
images were acquired with a 3xKalman line averaging. Tissues were excited with a 488nm
laser, while emission of the donor and acceptor were detected using photomultiplier tubes
(PMTs) with detection ranges set at 514–526nm (donor channel) and 566–578nm (acceptor
channel). All images were acquired with the exact same settings, i.e. PMT voltage, laser power
and pixel dwell time, to prevent hardware related misinterpretation of the FRET-values. Donor
bleed into the acceptor channel was determined by imaging the emission of 488-labeled Fn in
both channels. Donor bleed was constant throughout tissue depth and averaged 0.207 ± 0.001,
meaning that approximately 21% of the donor channel was present in the acceptor channel.
Because of the linear relation, i.e. donor bleed being constant throughout tissue depth, the
shape of the FRET-curves were not affected. Obtained Z-stack images were analyzed using a
modified version (automation of FRET measurements for Z-stacks was implemented) of a pre-
viously designed script in Matlab [10,31]. FRET-distributions were obtained by calculating the
average FRET value for each image in the Z-stack throughout the complete tissue depth. Previ-
ous work [10] showed that the FRET-signal itself is not affected by imaging through collagen-
based microtissues and thus truly represents a conformation change in the molecule.
The batch calibration of fibronectin FRET-ratios was performed using the technique as pre-
viously described [31] by dissolving FRET-labeled fibronectin at different concentrations of the
denaturant GdnHCl. The settings for visualization of the calibration curve using the Olympus
microscope were maintained when imaging FRET in 3D constructs.
Migration assay
Migration speed and persistence of MEFs was assessed on manually pulled plasma fibronectin
fibers, based on a previously developed system [32,76]. Fibronectin fibers were pulled from
solution (0.4 mg/mL plasma fibronectin in PBS) and deposited on silicone sheets (SMI .005”
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NRV G/G 40D, Specialty Manufacturing, Saginaw, MI) that were cut to fit a 4-well LabTek
chamber (#155382, Thermo Scientific). Fibronectin fibers were washed gently with PBS and
treated with 4% BSA in PBS for 60min. After washing with PBS, fibers were left untreated or
were decorated for 1h with rat tail collagen I (10μg/mL in DMEM at 37°C, BD Bioscience).
Subsequently, all fiber-containing silicone sheets were treated overnight with 20 mg/mL BSA,
10% PenStrep in PBS. After the migration assay, fibers were imaged for the presence of collagen
decoration for validation purposes.
Cytodex microcarrier beads (C3275, Sigma) coated with MEFs to near confluence were
used as sources of cells that could migrate away onto the fibronectin fibers. Briefly, MEFs
(0.3million) were suspended in 1mL growth medium and added to untreated 24-well plates
(351147, Falcon). Subsequently, 200μL of Cytodex beads (104 beads per mL of PBS) were
added to the wells. MEFs attached to the beads in the subsequent 72h of culturing. Cell-popu-
lated beads were transferred to fibronectin fibers (uncoated or coated with collagen) in fibro-
nectin-depleted FBS-rich (10%) growth medium. After 6h, MEFs started to migrate from the
beads onto the fibers. Migration was imaged time-lapsed using an Axiovert 200 M inverted
microscope (Carl Zeiss). Images were taken every 15min for 24h at multiple locations per
condition.
Migration speed was quantified using ImageJ software by selecting the position of individual
cells at every time point. Only those MEFs were tracked that migrated as a single cell and used
the fiber as guidance. Non-persistent cells were marked when changing direction at least once
during tracking.
Nanopillar experiments
SU-8 nanopillar arrays (SU-8 2000.5, Microchem) were fabricated by a combination of nano-
sphere lithography and plasma etching, attached to glass coverslips, as previously described [77].
Nanopillars were coated with vitronectin (10nM) or plasma fibronectin (10nM) via incubation
for 30min. MEFs, pre-labeled with membrane dye DiI (Invitrogen), were allowed to spread on
coated nanopillars at 7,500cells/cm2 in fibronectin-depleted growth medium. Growth medium
was, where indicated, supplemented with plasma fibronectin or the fibronectin fragments;
40kDa, 70kDa and 120kDa (final concentration 45nM). After 2h or 24h, cells were fixed in 10%
formalin for 30min after which pillar deflection and cell morphology was imaged using a Leica
confocal microscope SP5 with a 63x, oil immersion, 1.4 N.A. objective. Pillar displacements were
measured using Diatrack 3.03 (Powerful Particle Tracking, Semasopht). Atomic force micros-
copy was used to determine the spring constant of single nanopillars, resulting in an average
value of 79 ± 3 nN/μm. To calculate the total strain energy for each cell, the displacement of each
post was squared and multiplied by half the spring constant of a nanopillar and summed for all
pillars that connected to that cell, as described previously [53,54].
Statistics
For the migration assay, One-Way ANOVA was used to determine the effect of the coating
and its interaction with migration speed. For cellular force measurements on the nanopillars,
One-Way ANOVA was used to determine the effect of the combination of cell type and growth
medium content (using the same coating, either fibronectin or vitronectin) and its interaction
with total strain energy. For comparing the distributions of nuclei and fibronectin relative to
the collagen core (S2 Fig), One-Way ANOVA was used to detect significant differences in the
percentage of cells or Fn between bottom, core and top of tissues from different conditions. For
ANOVA, all p-values were corrected with the Bonferroni criterion. Student’s t-tests were per-
formed to check for significant differences between MEFs (analysis performed for Fnf/f and
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Fn-/-, separately) that showed persistent migration vs non persistent migration on collagen dec-
orated pFn fibers. Student T-tests were also performed to test for significant differences
between maximum fibronectin FRET-value and cell type (Fn-/- versus Fnf/f MEFs) for each
time point (24h, 48h and 72h) and for total strain energy of Fn-/- MEFs on fibronectin vs vitro-
nectin coated nanopillars. P-values<0.05 were considered statistically significant. The indi-
cated sample size originates from at least 2 different wells, in which differences between the
independent experiments were not observed.
Supporting Information
S1 Fig. The presence of fibronectin contributes to microtissue morphogenesis in a time-
dependent manner. Tissues either contained Fnf/f MEFs (A) or Fn-/- MEFs (B) in rat tail colla-
gen gels, supplemented with plasma fibronectin in the growth medium. MEFs produced shell
like tissues from 48-72h, where at 72h cells reside primarily apically from the collagen core,
with sparse cells at the basal side of the collagen core. The depth-dependent distributions of
cells and ECM components in a single tissue are represented by volume rendering using Imaris
software in a bottom and top view (1st and 2nd column) and a maximum projection cross-section
of the tissue with associated depth-dependent intensity histogram (3rd and 4th column, nuclei in
blue; collagen in green and plasma fibronectin in red)). Tissue depth in the histograms is repre-
sented as the distance from the location in the tissue with maximum collagen intensity (0μm).
The depth-dependent intensity histogram of all tissues combined is depicted in the 5th column,
which represents the raw data. Strikingly, Fn-/- MEFs assemble more fibronectin at the tissue sur-
face, visible at 72h, compared to their floxed counterparts. To note, the data presented for Fnf/f
MEFs at 72h resemble Fig 2A, while data for Fn-/- MEFs at 72h resemble Fig 2C. Percentage over-
lap of collagen and nuclei at the tissue bottom, core and top are quantified in S2 Fig.
(TIF)
S2 Fig. Quantification of the depth-dependent collagen-nuclei overlap in microtissues. (A)
Method of quantifying the distributions of cells and ECM (collagen and fibronectin) through-
out microtissue depth, as explained in the materials and methods section. The collagen core is
defined as the sum intensities from an arbitrary threshold of 0.5, resulting in three regions, i.e.
bottom, core and top. Subsequently, percentages based on sum intensity for the three different
tissue sections are calculated for nuclei (blue curve), collagen (green curve) and fibronectin
(red curve). (B-D) Distributions of nuclei, collagen and fibronectin in the different tissue zones
(bottom, core and top), in which error bars represent standard deviations. Analyses represent
histograms presented in Fig 2 (S2B Fig), Fig 5 (S2C Fig: fragments) and S1 Fig A (S2D Fig:
time-course of Fnf/f MEFs) and S1B Fig (S2E Fig: time-course Fn-/- MEFs). Analysis of statisti-
cal differences between the percentages in ‘bottom’, ‘core’ and ‘top’ are performed using One-
Way-ANOVA with a Bonferroni post hoc test.
(EPS)
S3 Fig. Cellular traction forces (2 and 24h after seeding), represented by average strain
energy per pillar, for different pillar coatings (fibronectin versus vitronectin) and in the
presence of exogenously added pFn and of its fragments. Compared to total strain energy
(Fig 4), similar trends are visible, however values at 24h for average strain energy are slightly
lower, resulting from an increased spreading area between 2h and 24h after cell seeding.
(EPS)
S4 Fig. Western blot analysis of the 70k fibronectin fragment shows a possible contamina-
tion with full length fibronectin. 1μg of the 70k fibronectin fragment was loaded and probed
with a rabbit polyclonal antibody against fibronectin (ab23750, Abcam). Although the majority
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of the protein consists of the 70k fragment, a possible contamination of fibronectin monomer
can be seen at band size 250. This may explain the slightly elevated cellular traction forces mea-
sured using the nanopillar assay.
(EPS)
S5 Fig. Calibration of fibronectin FRET-ratios in solution upon progressive denaturation.
FRET-labeled fibronectin was dissolved in different concentrations of the denaturant GndHCl.
The loss of secondary structure of the fibronectin protein starts beyond the concentration of 1M
GndHCl [31,48] (corresponding to acceptor-versus donor intensities, Ia/Id = 0.63 and higher).
The protein is completely denatured at GndHCl concentrations of 4M (la/ld = 0.37). Left: Proba-
bility density distributions of FRET-fibronectin in solutions at different GndHCl concentrations.
Right: The denaturation curve containing average values from 3 individual measurements of the
probability density distributions are presented in combination with the standard deviation.
(EPS)
S1 Movie. Representative Z-Stack of a tissue from Fig 2A: Fnf/f MEFs in a collagen gel at
72h of culturing.
(AVI)
S2 Movie. Representative Z-Stack of a tissue from Fig 2B: Fnf/f MEFs in a collagen gel at
72h of culturing with exogenously added plasma fibronectin.
(AVI)
S3 Movie. Representative Z-Stack of a tissue from Fig 2C: Fn-/- MEFs in a collagen gel at
72h of culturing.
(AVI)
S4 Movie. Representative Z-Stack of a tissue from Fig 2D: Fn-/- MEFs in a collagen gel at
72h of culturing with exogenously added plasma fibronectin.
(AVI)
S5 Movie. Representative Z-Stack of a tissue from S1 Fig A 24h: Fnf/f MEFs in a collagen gel
at 24h of culturing with exogenously added plasma fibronectin.
(AVI)
S6 Movie. Representative Z-Stack of a tissue from S1A Fig 48h: Fnf/f MEFs in a collagen gel
at 48h of culturing with exogenously added plasma fibronectin.
(AVI)
S7 Movie. Representative Z-Stack of a tissue from S1B Fig 24h: Fn-/- MEFs in a collagen gel
at 24h of culturing with exogenously added plasma fibronectin.
(AVI)
S8 Movie. Representative Z-Stack of a tissue from S1B Fig 48h: Fn-/- MEFs in a collagen gel
at 48h of culturing with exogenously added plasma fibronectin.
(AVI)
S9 Movie. Representative Z-Stack of a tissue from Fig 5A: Fn-/- MEFs in a collagen gel at
72h of culturing supplemented with the 40kDa fibronectin fragment.
(AVI)
S10 Movie. Representative Z-Stack of a tissue from Fig 5B: Fn-/- MEFs in a collagen gel at
72h of culturing supplemented with the 70kDa fibronectin fragment.
(AVI)
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S11 Movie. Representative Z-Stack of a tissue from Fig 5C: Fn-/- MEFs in a collagen gel at
72h of culturing supplemented with the 120kDa fibronectin fragment.
(AVI)
S12 Movie. Representative FRET-distribution in a tissue from Fig 6A 24h: Fnf/f MEFs in a
collagen gel at 24h of culturing supplemented with FRET-labeled fibronectin.
(AVI)
S13 Movie. Representative FRET-distribution in a tissue from Fig 6A 48h: Fnf/f MEFs in a
collagen gel at 48h of culturing supplemented with FRET-labeled fibronectin.
(AVI)
S14 Movie. Representative FRET-distribution in a tissue from Fig 6A 72h: Fnf/f MEFs in a
collagen gel at 72h of culturing supplemented with FRET-labeled fibronectin.
(AVI)
S15 Movie. Representative FRET-distribution in a tissue from Fig 6B 24h: Fn-/- MEFs in a
collagen gel at 24h of culturing supplemented with FRET-labeled fibronectin.
(AVI)
S16 Movie. Representative FRET-distribution in a tissue from Fig 6B 48h: Fn-/- MEFs in a
collagen gel at 48h of culturing supplemented with FRET-labeled fibronectin.
(AVI)
S17 Movie. Representative FRET-distribution in a tissue from Fig 6B 72h: Fn-/- MEFs in a
collagen gel at 72h of culturing supplemented with FRET-labeled fibronectin.
(AVI)
S18 Movie. Representative FRET-distribution in a tissue from Fig 6B 96h: Fn-/- MEFs in a
collagen gel at 96h of culturing supplemented with FRET-labeled fibronectin.
(AVI)
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